Cargando…
CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
On a per capita basis, Canadian drug costs are already the second highest in the world after the United States and are among the fastest rising in the Organization for Economic Co-Operation and Development. The Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Can...
Autores principales: | Lexchin, Joel, Gagnon, Marc-André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108121/ https://www.ncbi.nlm.nih.gov/pubmed/24885309 http://dx.doi.org/10.1186/1744-8603-10-30 |
Ejemplares similares
-
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
por: Morgan, Steven G., et al.
Publicado: (2016) -
'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007) -
Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011) -
Models for financing the regulation of pharmaceutical promotion
por: Lexchin, Joel
Publicado: (2012) -
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
por: Gleeson, Deborah, et al.
Publicado: (2019)